eCommons

 

Circulating Tumor Cells as Diagnostic Tools and Therapeutic Targets

Other Titles

Abstract

Circulating tumor cells have been a major area of focus for cancer metastasis research for the last few decades, and while the majority of progress has mainly centered on the isolation and enumeration of CTC for prognostic purposes, researchers are beginning to explore additional uses for CTC in the clinical setting. While it is well known that CTC counts correlate with prognosis, CTC counts are also being explored as a marker for response to therapy. CTC enumerated before and after surgical procedures are shedding light on the advantages of minimally invasive techniques. CTC characterization has also increased in the past decade. When CTC were first reliably isolated, the majority of work focused solely on EpCAM-expressing cells found within the blood of patients with late stage cancer. Today, EpCAM-negative CTC and CTC expressing mesenchymal markers are under great scrutiny for a potentially increased metastatic potential. Moreover, CTC that differ in protein and gene expression to the primary tumor have been found elucidating prospective issues with drug targets. CTC have been isolated and identified in patients with local tumors or even pre-cancerous lesions. Here, we present a diagnostic method that uses CTC to prescreen for drug susceptibility. This method is then used to show primary CTC sensitivity to a novel TRAIL-based immunotherapeutic targeted towards CTC. Peripheral blood samples are shown to contain circulating stromal cells believed to migrate alongside CTC and likely alter their survival under shear conditions as well as their drug susceptibility. We culminate these studies by conducting the first efficacy study of EST liposomes in an immunocompetent breast cancer tumor resection murine model.

Journal / Series

Volume & Issue

Description

Sponsorship

Date Issued

2017-01-30

Publisher

Keywords

metastasis; TRAIL; Biomedical engineering; E-selectin; cancer; cancer-associated fibroblast; circulating tumor cell

Location

Effective Date

Expiration Date

Sector

Employer

Union

Union Local

NAICS

Number of Workers

Committee Chair

King, Michael R.

Committee Co-Chair

Committee Member

Lindau, Manfred
Daniel, Susan

Degree Discipline

Biomedical Engineering

Degree Name

Ph. D., Biomedical Engineering

Degree Level

Doctor of Philosophy

Related Version

Related DOI

Related To

Related Part

Based on Related Item

Has Other Format(s)

Part of Related Item

Related To

Related Publication(s)

Link(s) to Related Publication(s)

References

Link(s) to Reference(s)

Previously Published As

Government Document

ISBN

ISMN

ISSN

Other Identifiers

Rights

Attribution-NonCommercial-ShareAlike 4.0 International

Types

dissertation or thesis

Accessibility Feature

Accessibility Hazard

Accessibility Summary

Link(s) to Catalog Record